Anti-PDL1 antibody

Anti-PDL1 antibody

Monclonal rabbit antibody for diagnostic use

Features :
  • Rabbit monoclonal antibody
  • GeneAb recombinant monoclonal antibodies are engineered to deliver consistent, specific, and sensitive stains
  • Several sizes available : Concentrate (0.1 and 1 ml) and Predilute (7 ml)
  • Positive control slides available
  • Validated for Leica BOND-MAX
PD-L1 (IHC411) antibody is intended for in vitro diagnostic (IVD) use.
This antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods.

Programmed Death-Ligand 1 (PD-L1), also known as CD274 or B7 Homolog 1 (B7-H1), is a transmembrane protein involved in suppressing the immune system and rendering tumor cells resistant to CD8+ T cell-mediated lysis through binding of the Programmed Death-1 (PD-1) receptor.
Overexpression of PD-L1 may allow cancer cells to evade the actions of the host immune system. In renal cell carcinoma, upregulation of PD-L1 has been linked to increased tumor aggressiveness and risk of death, and, in ovarian cancer, higher expression of this protein has lead to significantly poorer prognosis. PD-L1 has also been linked to systemic lupus erythematosus and cutaneous melanoma. When considered in adjunct with CD8+ tumor-infiltrating lymphocyte density, expression levels of PD-L1 may be a useful predictor of multiple cancer types, including stage III non-small cell lung cancer, hormone receptor negative breast cancer, and sentinel lymph node melanoma.

Product code
Target
PD-L1
Type
Rabbit monoclonal antibody
Clone
IHC411
Size
0.1 ml / 1 ml (concentrate) ; 7 ml (predilute)
Application
IHC
Dilution
1: 100 - 1: 200
Pre-treatment
HIER pH9
Positive control
tonsil and lung adenocarcinoma


PDL1 
GeneAbTM PD-L1 (IHC411) on lung cancer